Perinatal depression is common and carries considerable risks, yet patients often receive contradictory information regarding the safety of antidepressant use during pregnancy and breastfeeding. In this article, Lucy Broughton sets the record straight and explains how pharmacists can support this important treatment decision
Dulaglutide use doubles as supply dwindles
+News
In print
Dulaglutide use doubles as supply dwindles
Tuesday 7 November 2023, 09:37 AM

People with type 2 diabetes are likely to be affected by supply issues with dulaglutide (Trulicity) [Image: Raimond Spekking CC BY-SA 4.0 via Wikimedia Commons]
The number of people taking funded dulaglutide (Trulicity) has doubled in New Zealand over the past two years and the diabetes medicine is in short supply again, along with its alternative, Victoza (liraglutide). Natasha Jojoa Burling reports
Some pharmacists say the diabetes medications dulaglutide and liraglutide are growing in popularity as a potential weight-loss tool in New Zealand, an